Evening Symposium 1

Objectives:

Despite significant advances in the treatment of rheumatoid arthritis (RA) and lupus nephritis (LN), maintaining long-term disease control remains a challenge in routine clinical practice. Supported by extensive clinical and real-world experience in Asia, tacrolimus continues to play an important role in individualized rheumatic disease management.

Key topics include:

• Long-Term Disease Control in Rheumatoid Arthritis
  Exploring the role of tacrolimus in sustained disease control, treatment maintenance, safety and individualized patient management through real-world experience.
• Optimizing Long-Term Management in Lupus Nephritis
  Practical approaches to sustained disease control, renal protection, and long-term patient outcomes.

By integrating clinical evidence and real-world practice, this symposium aims to provide practical insights into the evolving role of tacrolimus in achieving long-term treatment success in RA and LN.